Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Morgan

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|May 29, 2017
Diagnostic accuracy of post-mortem CT with targeted coronary angiography versus autopsy for coroner-requested post-mortem investigations: a prospective, masked, comparison studyGuy N Rutty, Bruno Morgan, Claire Robinson, et al.
The Lancet. Respiratory Medicine|January 30, 2021
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trialDean A Fennell, Amy King, Seid Mohammed, et al.
International Journal of Legal Medicine|October 19, 2012
Terminology used in publications for post-mortem cross-sectional imagingGuy N Rutty, Gil Brogdon, Fabrice Dedouit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and complianceRicky A Sharma, Stephanie A Euden, Sharon L Platton, et al.
Radiology|May 2, 2018
Postmortem CT Angiography Compared with Autopsy: A Forensic Multicenter StudySilke Grabherr, Axel Heinemann, Hermann Vogel, et al.
Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.
British Journal of Cancer|October 21, 2021
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penisSteve Nicholson, Holly Tovey, Tony Elliott, et al.
The Journal of Nutrition|May 28, 2019
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa TrialLynne M Howells, Chinenye O O Iwuji, Glen R B Irving, et al.
The Lancet. Oncology|February 14, 2022
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trialDean A Fennell, Amy King, Seid Mohammed, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2009
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerGiorgio V Scagliotti, Paul Germonpré, Leon Bosquée, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|May 29, 2017
Diagnostic accuracy of post-mortem CT with targeted coronary angiography versus autopsy for coroner-requested post-mortem investigations: a prospective, masked, comparison studyGuy N Rutty, Bruno Morgan, Claire Robinson, et al.
The Lancet. Respiratory Medicine|January 30, 2021
Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trialDean A Fennell, Amy King, Seid Mohammed, et al.
International Journal of Legal Medicine|October 19, 2012
Terminology used in publications for post-mortem cross-sectional imagingGuy N Rutty, Gil Brogdon, Fabrice Dedouit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and complianceRicky A Sharma, Stephanie A Euden, Sharon L Platton, et al.
Radiology|May 2, 2018
Postmortem CT Angiography Compared with Autopsy: A Forensic Multicenter StudySilke Grabherr, Axel Heinemann, Hermann Vogel, et al.
Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.
British Journal of Cancer|October 21, 2021
VinCaP: a phase II trial of vinflunine in locally advanced and metastatic squamous carcinoma of the penisSteve Nicholson, Holly Tovey, Tony Elliott, et al.
The Journal of Nutrition|May 28, 2019
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa TrialLynne M Howells, Chinenye O O Iwuji, Glen R B Irving, et al.
The Lancet. Oncology|February 14, 2022
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trialDean A Fennell, Amy King, Seid Mohammed, et al.
Lung Cancer (Amsterdam, Netherlands)|August 21, 2009
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerGiorgio V Scagliotti, Paul Germonpré, Leon Bosquée, et al.
Pageof 7